4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-011810
Director bought 11,750 shares at an average $1.25 ($14,663)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flynn Patrick John Director | 2022-11-28 | Purchase | +2,500 | $1.25 | $3,125 | 37,709 | I |
| Flynn Patrick John Director | 2022-11-28 | Purchase | +2,500 | $1.25 | $3,125 | 40,209 | I |
| Flynn Patrick John Director | 2022-11-28 | Purchase | +2,500 | $1.25 | $3,125 | 37,709 | I |
| Flynn Patrick John Director | 2022-11-28 | Purchase | +2,500 | $1.24 | $3,100 | 40,209 | I |
| Flynn Patrick John Director | 2022-11-28 | Purchase | +1,750 | $1.25 | $2,188 | 1,750 | D |
| Open-market purchases · 11,750 sh · avg $1.25 · $14,663 | |||||||
Loading xslF345X03/form4-11292022_071101.xml…